Search

Your search keyword '"Suresh Azimeera"' showing total 2 results
Start Over Author "Suresh Azimeera" Topic genetic structures
2 results on '"Suresh Azimeera"'

1. Study on change in corneal biomechanics and effect of percent tissue altered in myopic laser-assisted in situ keratomileusis

Author

Suresh Azimeera, Radhika Tandon, Murugesan Vanathi, and Noopur Gupta

Subjects
medicine.medical_specialty, endocrine system, genetic structures, medicine.medical_treatment, Keratomileusis, Laser In Situ, Subgroup analysis, Keratomileusis, LASIK, biomechanics, Corneal hysteresis, resistance, Cornea, Ophthalmology, Myopia, Medicine, Humans, Prospective Studies, medicine.diagnostic_test, business.industry, Biomechanics, flap thickness, Corneal Topography, CRF, CH, Corneal topography, Laser assisted, eye diseases, Ablation depth, Biomechanical Phenomena, PTA, medicine.anatomical_structure, hysteresis, correlation, laser ablation, Original Article, Lasers, Excimer, sense organs, business, cornea resistance factor
Abstract

Purpose: To evaluate corneal biomechanical changes and their correlation with the percentage of tissue altered (PTA) in myopic femtosecond (FS)-flap LASIK. Methods: Prospective longitudinal observational study of 80 eyes of FS LASIK. Demographic details, LASIK parameters, preoperative and postoperative (day 1, month 1, 3, and 6), UCVA, BCVA, refraction, corneal topography, corneal hysteresis (CH), and a corneal resistance factor (CRF) were noted. Change in CH and CRF and its correlation with PTA were analyzed. Data were analyzed in three subgroups [subgroup 1: PTA 23 to

Published
2020

2. Post-Ranibizumab injection endophthalmitis in aggressive posterior retinopathy of prematurity

Author

Devesh Kumawat, Suresh Azimeera, Parijat Chandra, and Ruchir Tewari

Subjects
medicine.medical_specialty, genetic structures, medicine.medical_treatment, Vitrectomy, Meropenem, 03 medical and health sciences, 0302 clinical medicine, Endophthalmitis, lcsh:Ophthalmology, Ophthalmology, medicine, retinopathy of prematurity, ranibizumab, Dexamethasone, vascular endothelial growth factor, business.industry, Retinopathy of prematurity, medicine.disease, eye diseases, Vitreous membrane, Intravenous therapy, lcsh:RE1-994, 030221 ophthalmology & optometry, Ranibizumab, business, 030217 neurology & neurosurgery, medicine.drug
Abstract

A preterm infant with zone 1 aggressive posterior retinopathy of prematurity developed infectious endophthalmitis after intravitreal injection of ranibizumab. Urgent empirical intravitreal therapy with vancomycin, ceftazidime, and dexamethasone along with intravenous therapy with amikacin and meropenem helped in early resolution. Vascularization/activity of disease subsided on follow-up, media cleared, and laser photocoagulation was completed. Later the disease reactivated, developed vitreous membranes and central retinal traction, for which 25-gauge lens-sparing vitrectomy was performed. Emergent treatment helped in salvaging the eye from both aggressive ROP disease and devastating endophthalmitis. Rationale approach to such a case is being discussed.

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results